Clinical trials
Terminated Liposarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Benjamin Izar | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| City of Hope Medical Center | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Institut Bergonié | 1 |
| Mayo Clinic | 1 |
| Numab Therapeutics AG | 1 |
| Pfizer | 1 |
| Rain Oncology Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liposarcoma | 14 |
| Sarcoma | 8 |
| Leiomyosarcoma | 5 |
| Fallopian Tube Neoplasms | 2 |
| Hemangiosarcoma | 2 |
| Mesothelioma, Malignant | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Sarcoma, Ewing | 2 |
Trials
Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.